The application of the principle of equivalence to the clinical evaluation of medical devices is particularly challenging.

We know very well what a significant change of (medical) devices is in the scope of the MDR since the publication of MDCG 2020-3 Rev1.

The use of clinical data of a "similar" medical device based on the principle of equivalence is highly problematic.

We present you with a summary of the newly published Q&A addressing the practical aspects of fulfilling the manufacturer's new obligation.

Amendments to EU regulations will be approved, mandating earlier Eudamed use. Gradual use starts Q4 2025, fully by Q4 2027.

“When the device is intended for professional use only, instructions for use may be provided to the user in non-paper format (e.g....

In January, the European Commission published a proposal for another amendment to the MDR and IVDR, which brings a number of major new...

A major issue for healthcare providers is the application of Article 5(5) of the IVDR. The issue is that in many cases clinical...

We can infer where the medical device market will go in 2024 from the previous year's news. At least partially. The year 2023 would...

The turn of the year is always accompanied by some kind of taking stock of what has happened in the past year. As far as the medical...